Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Imaging Services

 

Digital Transformation 5: What next? The future of interventions

Where do we go from here? Technology is driving all aspects of healthcare, not least in surgical intervention. A field of constant innovation in a strive for higher success rates, fewer side effects, reduced length of stay and increased patient satisfaction are all driven by reduced complexity and lower invasiveness. This session explores how technology, […]

Diagnostics: Sector Analysis

Covid-19 massively boosted lab revenues. But will labs retain the special relationship they have built with governments?  US groups, for instance, are monetising their data by working with payors on disease prevention. How are labs using digital to help doctors interpret results and to reach the consumer? Confirmed speakers include: Michiel Boehmer, Unilabs Evangelos Kotsopoulos, […]

Digital Transformation 4: Reinventing primary care and diagnostics

   What does fully digitised primary care look like? And what new diagnostics can be carried out digitally? What impact will this have on health care models and tariffs? We have already seen digital health players buying up physical clinics. Will this trend continue? Confirmed speakers include: Giuseppe Recchi, Affidea Petri Bono, Terveystalo Daniel Nathrath, Ada […]

Keynote: The Future of Healthcare

Helios Fresenius is by far the largest European for-profit hospital operator with over €9.8bn of revenue in Germany and Spain. It is also active in Latin America and its digital health platform, Curalie, is a global contender in diagnosis, physician selection, treatment and rehabilitation. Its acquisition of Eugin also makes it one of the largest […]

How Affidea is driving 10% MRI scan growth

European imaging provider Affidea sees 10% volume growth on MRI scans where it has deployed a programme to track how and when machines are used with proprietary software. Senior VP regional COO Zisis Sotiriou talks to HBI about how it has optimised clinical protocols, identified efficiency savings and gained an extra €2m revenue a year.

Market conditions right for Unilabs to sell

HBI hears rumour that pan-European laboratory and imaging group Unilabs could sell soon. We explore how its private equity owner Apax could make a much-anticipated exit. 

Global names on Saudi imaging PPP shortlist but ‘no decision yet’

Alliance, Affidea, Ribera Salud and InHealth are all among the eight name shortlist for Saudi Arabia's massive radiology private public partnership. However, a source in the market tells HBI that progress is still slow and a decision has not been made on a winner.

Rede D’Or backs down on Alliar

Brazilian hospital group Rede D'Or has pulled back on its attempt to takeover imaging group Alliar after it became clear it could not take control. However, large lab group Fleury has now also thrown its hat into the ring for a stake.

Find Us